Preparation of poly(lactic acid)/chitosan nanoparticles for anti-HIV drug delivery applications

Carbohydrate Polymers

Volumn 80, Issue 3, 2010, Pages 833-838

  Dev, Ashish ^a   Binulal, N S ^a   Anitha, A ^a   Nair, S V ^a   Furuike, T ^b   Tamura, H ^b   Jayakumar, R ^a  

^a AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

^b KANSAI UNIVERSITY   (Japan)

Author keywords

Chitosan; Controlled drug delivery; Emulsion; Lamivudine drug; Nanoparticles; Poly(lactic acid)

Indexed keywords

ACIDIC PH; ALKALINE PH; ANTI-HIV; ANTIRETROVIRAL DRUGS; CARRIER SYSTEMS; CATIONIC GROUPS; CHITOSAN NANOPARTICLES; CONTROLLED DELIVERY; DRUG DELIVERY APPLICATIONS; DRUG NANOPARTICLES; DRUG-RELEASE RATE; EMULSION METHOD; ENCAPSULATION EFFICIENCY; FTIR; IN-VITRO; LAMIVUDINE; MTT ASSAYS; POLY(LACTIC ACID); POLYLACTIC ACIDS; POLYMERIC NANOPARTICLES; SEM;

BODY FLUIDS; CHITIN; CHITOSAN; EMULSIFICATION; ENCAPSULATION; FOURIER TRANSFORM INFRARED SPECTROSCOPY; HYDROGELS; LACTIC ACID; NANOPARTICLES; ORGANIC ACIDS; SCANNING ELECTRON MICROSCOPY; VIRUSES;

CONTROLLED DRUG DELIVERY;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 77949658846     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2009.12.040     Document Type: Article

References (33)

1. Agnihotri S.A., and Aminabhavi T.M. Controlled release of colzapine through chitosan microparticles prepared by a novel method. Journal of Controlled Release 96 (2004) 245-259
2. Anderson K.S. Perspectives on the molecular mechanism of inhibition and toxicity of nucleoside analogs that target HIV-1 reverse transcriptase. Biochimica et Biophysica Acta 158 (2002) 296-299
3. Bajaj A., and Desai M. Challenges and strategies on nano drug delivery technologies. Pharma Times 38 (2006) 12-16
4. Bergma J., De Bruijin W.D., Rozema F.R., Bos R.R.M., and Boering G. Late degradation tissue response to poly (l-lactide) bone plates and screws. Biomaterials 16 (1995) 25-33
5. Caroline M.P., and Faulds D. Lamivudine: A review of its antiretroviral activity. Pharmacokinetic property and therapeutic efficiency in management of HIV infection. Drugs 53 (1997) 7-680
6. Chen Y.W. Concept and system design for rate controlled delivery, novel drug delivery systems, and drug and pharmaceutical sciences (1992), Marcel Dekker, NY
7. Clercq E.D. New developments in anti-HIV chemotherapy. Biochimica et Biophysica Acta 158 (2002) 257-258
8. Dutta J., Tripathi V.S., Chattopadhyaya M.C., and Dutta P.K. FTIR spectroscopic and rheological study of chitosan-lactic acid based gels. Asian Chitin Journal 1 (2005) 79-86
9. Fernandes C. Dissolution test for Lamivudine tablets: Optimization and statistical analysis. Journal of Pharmaceutical and Biomedical Analysis 42 (2006) 601-606
10. Gonzalez M.F., Ruseckalite R.A., and Cuadrado T.R. Structural changes of poly lactic acid (PLA) microspheres under hydrolitic degradation. Journal of Applied Polymer Science 71 (1999) 1223-1230
11. Inez M.V., Kersten G., Marjan M.F., Beuvery C., Verhoef J.C., and Junginger H.E. Chitosan microparticles for mucosal vaccination against diphtheria: Oral and nasal efficacy studies in mice. Vaccine 21 (2003) 13-14
12. Jayakumar R., Chennazhi K.P., Muzzarelli R.A.A., Tamura H., Nair S.V., and Selvamurugan N. Chitosan conjugated DNA nanoparticles in gene therapy. Carbohydrate Polymers 79 (2010) 1-8
13. Jayakumar R., Nwe N., Tokura S., and Tamura H. Sulfated chitin and chitosan as novel biomaterials. International Journal of Biological Macromolecules 40 (2007) 175-181
14. Jayakumar R., Prabaharan M., Nair S.V., and Tamura H. Novel chitin and chitosan nanofibers in biomedical applications. Biotechnology Advances 28 (2010) 142-150
15. Jayakumar R., Prabaharan M., Reis R.L., and Mano J.F. Graft copolymerized chitosan - Present status and applications. Carbohydrate Polymers 62 (2005) 142-158
16. Jayakumar R., Reis R.L., and Mano J.F. Syntheiss and characterization of pH sensitive thiol containing chitosan beads for controlled drug delivery applications. Drug Delivery 14 (2007) 9-17
17. Jozwiakowski M.J., Nguyen N.T., Sisco J.M., and Spancake C.W. Solubility behaviour of Lamivudine crystal forms in recrystallization solvents. Journal of Pharmaceutical Sciences 85 (1996) 193-199
18. Kao J.H., Wu N.H., Chen P.J., Lai M.Y., and Chen D.S. Hepatitis B genotype and response to interferon therapy. Journal of Hepatology 33 (2000) 998-1002
19. Khor E. Chitin: Fulfilling a biomaterials promise (2001), Elsevier Science, Oxford, UK
20. Kim K., Yu M.K., Hsiao B.S., and Chu B. Control of degradation rate and hydrophilicity in electrospun non-woven poly (d,l-lactide) nanofiber scaffolds for biomedical applications. Biomaterials 24 (2003) 4977-4985
21. Lathia J.D., Leodore L., and Wheatley M.A. Polymeric contrast agent with targeting potential. Ultrasonics 42 (2004) 763-768
22. Ma Z.W., Gao C.Y., Gong Y.H., and Shen J.C. Paraffin spheres as porogen to fabricate poly(l-lactic acid) scaffolds with improved cytocompatibility for cartilage tissue engineering. Journal of Biomedical Materials Research 67B (2003) 610-617
23. Muzzarelli R.A.A. Chitin. (pp. 1-37) (1977), Pergamon, Elmsford, NY
24. O'Donnell P.B., and Mc Ginity J.W. Preparation of microspheres by the solvent evaporation technique. Advanced Drug Delivery Reviews 28 (1997) 25-42
25. Park S.J., and Kim S.H. Preparation and characterization of biodegradable poly (l-lactide)/poly (ethylene glycol) microcapsules containing erythromycin by emulsion solvent evaporation technique. Journal of Colloid Interface Science 271 (2004) 336-341
26. Prabaharan M., and Mano J.F. Chitosan-based particles for controlled drug delivery systems. Drug delivery 12 (2005) 41-57
27. Prabaharan M., Grailer J.J., Pilla S., Steeber D.A., and Gong S. Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn® H40, poly(l-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery. Biomaterials 30 (2009) 3009-3019
28. Proikalis C.S., Tarantalli P.A., and Andreopoulos A.G. The role of polymer/drug interactions on the sustained release from poly (dl-lactic acid) tablets. European Polymer Journal 42 (2006) 3269-3276
29. Roberts G.A.F. Chitin chemistry (1992), MacMillan Press, Houndmills
30. Shin I.G., Kim S.Y., Lee Y.M., Cho C.S., and Sung Y.K. Methoxy poly(ethylene glycol)/E-caprolactone amphiphilic block copolymeric micelle containing indomethacin: I. Preparation and characterization. Journal of Controlled Release 51 (1998) 1-11
31. Suh H., Hwang Y.S., Lee J.E., Han C.D., and Park J.C. Behaviour of osteoblasts on a type collagen grafted ozone oxidized poly (l-lactic acid) membrane. Biomaterials 22 (2001) 219-230
32. Yzdanian M. Blood brain barrier properties of human immunodeficiency virus antiretrovirals. Journal of Pharmaceutical Sciences 88 (1999) 950-954
33. Zhao Y., Fu J., Dennis K.P.N., and Wu C. Formation and degradation of poly (d,l-lactide) nanoparticles and their potential application as controllable releasing devices. Macromolecular Bioscience 4 (2004) 901-906